Upregulation of MEG3, by regulating insulin signaling in the brain, may offer neuroprotective effects and potentially alleviate cognitive impairment and neuronal damage associated with AD pathogenesis [25]. This evidence concerns the gene MEG3 and Cognitive impairment.